Active ingredient: Methylsilicic acid hydrogel (in 100 g of the preparation – 70 g). Auxiliary ingredients: purified water, sweetener.
The active ingredient of enterosgel is methylsilicic acid in the form of a hydrogel. The drug belongs to the enterosorbent. It has a detoxifying effect when taken orally. The silicon-organic matrix of the methylsilicic acid hydrogel effectively absorbs from the blood (due to the action of intestinal mucous membrane cells through the villus membranes) and from the intestinal contents, products of incomplete metabolic reactions, medium-molecular toxic substances (with a molecular mass of 70-1000) and incorporated radionuclides. After absorption, removes them from the body with feces. Also binds and removes microorganisms (conditionally pathogenic and pathogenic). Does not inhibit coli, lacto-and bifidobacteria due to the reduced adhesiveness of the normal intestinal microflora. Suppresses manifestations of toxicosis, normalizes laboratory parameters of urine and blood, improves the functioning of the liver, kidneys and intestines. Prevents the development of erosive-ulcerative lesions of the mucous membrane of the gastrointestinal tract when exposed to aggressive external factors due to the enveloping action. Improves parietal digestion. It activates the peristaltic movements of the intestines, does not cause atony. The drug is not absorbed into the systemic circulation. Stabilizes immune responses through effective detoxification.
Indications for use
• Infectious-toxic liver diseases (viral hepatitis A and B, toxic hepatitis, cirrhosis of the liver, hepatocholecystitis); • kidney disease, especially with the development of chronic renal failure (glomerulonephritis, pyelonephritis, polycystic kidney disease, etc.); • cholestasis of various origins, including the addition of allergic reactions and liver failure; • diseases of the gastrointestinal tract (enterocolitis, gastritis, colitis, diarrhea, post-resection syndrome, peptic ulcer and duodenal ulcer, etc.); • food and drug allergies, infectious-allergic and atopic bronchial asthma, atopic dermatitis, urticaria, eczema, etc.); • diarrhea and dyspepsia of non-infectious genesis, • infectious diseases (salmonellosis, foodborne toxicoinfection, dysentery, rotavirus infections); • intoxication (including narcotic, burn, purulent-septic and alcohol intoxication); • skin diseases (neurodermatitis, diathesis, etc.); • early preeclampsia, • complex treatment of intestinal dysbiosis, • malignant diseases (for detoxification before and after surgery, during radiation or chemotherapy).
Mode of application
Enterosgel appointed inside. Dosage form – paste – is completely ready for use. The duration of treatment is determined individually. On average, the duration of therapy is 7-14 days, in case of severe intoxication, an increase in the dose of 2 times in the first 3 days of therapy is possible. With obstructive jaundice and liver cirrhosis, it is possible to administer a longer time (2 months or more). Enterosgel should drink plenty of water. Take the drug should be between meals food (2 hours after taking a meal or drug, or 1.5-2 hours before taking). The daily dose (45 g for adults) is divided into 3 doses. A single dose – 1 tablespoon (15 g) – for adults. In pediatrics: children under 3 years old – 1 tsp (5 g) 2 times a day (daily dose – 10 g); children 3-5 years old – 1 teaspoon 3 times a day (daily dose – 15 g), children 5-14 years – 1 dessert spoon (10 g) 3 times a day (daily dose – 30 g).
Constipation may occur (especially in patients with a tendency to constipation) in the first days of taking the drug. With the development of constipation, it is recommended to carry out a cleansing enema (in the first 2 days of application of enterosgel).
Enterosgel is not prescribed for acute intestinal obstruction. After elimination of intestinal obstruction enterosgel is not contraindicated.
Enterosgel is not contraindicated during pregnancy and breastfeeding.
Enterosgel can be used in complex therapy, subject to the timing of enterosgel in relation to other drugs, including adaptogens, immunomodulators, bacterial preparations (lactobacilli, bifidobacteria) and herbal remedies.
If daily and single doses are exceeded, no negative effects on the body are described yet.
Paste for internal use in containers 135; 270; 405 g. Plastic container packed in a cardboard box.
Enterosgel stored at a temperature of 15-25 ° C. After opening the container, the drug should be protected from drying out. Shelf life 3 years. Sold without a prescription.